Search clinical trials for: Non-nodular Acne Vulgaris

Total 1439 results

Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

Acne Vulgaris

Poland, United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Acne Vulgaris

United States, Canada
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
GlaxoSmithKline

Completed

Study to Investigate the Irritation Potential of GSK1940029 Gel

Acne Vulgaris

Australia
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
University Hospital of Patras

Completed

Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections

Pain

Greece
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Thesan Pharmaceuticals, Inc.

Withdrawn

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Dominican Republic, Honduras
BioPharmX, Inc.

Completed

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (OPAL)

Acne Vulgaris

United States
Stiefel, a GSK Company

Completed

8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne

Acne Vulgaris
Bayer
RTI Health Solutions

Completed

Risk Minimisation Study for Diane-35 and Its Generics

Acne Vulgaris

France, Spain, Austria, Czech Republic, Netherlands
Bayer

Completed

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

Acne Vulgaris

United Kingdom, Italy, Netherlands
AOBiome LLC

Completed

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Galderma R&D

Completed

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Galderma R&D

Completed

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Acne Vulgaris

Japan
Galderma R&D

Completed

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
University of North Carolina, Chapel Hill
Celgene

Terminated

Apremilast in the Treatment of Moderate to Severe Acne

Acne

United States
Cairo University

Completed

Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne

Acne Vulgaris
MDbackline, LLC
Alcon Research

Completed

Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

Cataract

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
GlaxoSmithKline

Completed

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

Acne Vulgaris

China
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris (Narciso)

Acne Vulgaris
LEO Pharma

Completed

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Acne Vulgaris

France
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris (C0000-411)

Acne Vulgaris
Lumenis Be Ltd.

Terminated

Impact of the M22-IPL Acne Filter on Acne Vulgaris

Acne

United States
Mahidol University

Completed

An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne

Acne

Thailand
Vanderbilt University

Completed

Treatment of Orthostatic Hypotension in Autonomic Failure

Orthostatic Hypotension | Autonomic Failure

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

Acne Vulgaris

United States, Canada
All India Institute of Medical Sciences, Bhubaneswar

Completed

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

India
MBcure Ltd

Unknown

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

Acne
Seegpharm S.A.

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne

Acne Vulgaris

Argentina
Sadick Research Group

Withdrawn

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris (Chromogenix)

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline; Quintiles, Inc.; Rho, Inc.

Completed

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Acne Vulgaris

United States, Canada, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
G & W Laboratories Inc.

Completed

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
University of Michigan

Completed

Non-cutting Laser Therapy in the Treatment of Acne

Acne Vulgaris

United States

3

Subscribe